SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-22-006961
Filing Date
2022-06-27
Accepted
2022-06-27 17:10:17
Documents
1
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 form4a-06272022_020606.html 4/A  
1 form4a-06272022_020606.xml 4/A 4690
  Complete submission text file 0001415889-22-006961.txt   6238
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 415-801-8100
Graham G. Walmsley (Reporting) CIK: 0001777517 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-39712 | Film No.: 221045512